1.Welch N, Zhu M, Hua C, Weller J, Mirhashemi M, Nguyen T, Mantena S, Bauer M, Shaw B, Ackerman C, Thakku S, Tse M, Kehe J, Uwera M-M, Eversley J, Bielwaski D, McGrath G, Braidt J, Johnson J, Cerrato F, Moreno G, Krasilnikova L, Petros B, Gionet G, King E, Huard R, Jalbert S, Cleary M, Fitzgerald N, Gabriel S, Gallagher G, Smole S, Madoff L, Brown C, Keller M, Wilson M, Kirby M, Barnes J, Park D, Siddle K, Happi C, Hung D, Springer M, MacInnis B, Lemieux J, Rosenberg E, Branda J, Blainey P, Sabeti P, Myhrvold C. Multiplexed CRISPR-based microfluidic platform for clinical testing of respiratory viruses and identification of SARS-CoV-2 variants. Nat Med. 2022;28(5):1083–1094. PMCID: PMC9117129 Reference Link